MicroRNAs and tumor vasculature normalization: Impact on anti-tumor immune response

Archivum Immunologiae et Therapiae Experimentalis

Volumn 61, Issue 4, 2013, Pages 285-299

  Matejuk, Agata ^a,b   Collet, Guillaume ^a   Nadim, Mahdi ^a,c   Grillon, Catherine ^a   Kieda, Claudine ^a  

^a CENTRE DE BIOPHYSIQUE MOLÉCULAIRE   (France)

^b Le Studium   (France)

^c Libragen Induchem Company   (France)

Author keywords

Angiogenesis; Cancer; Hypoxia; MicroRNAs regulation; Tumor immune response; Vessels normalization

Indexed keywords

ANGIOPOIETIN 1; ANGIOPOIETIN 2; ANGIOPOIETIN RECEPTOR; MICRORNA; MICRORNA 107; MICRORNA 125A; MICRORNA 126; MICRORNA 130A; MICRORNA 15; MICRORNA 150; MICRORNA 155; MICRORNA 16; MICRORNA 199A; MICRORNA 21; MICRORNA 221; MICRORNA 222; MICRORNA 223; MICRORNA 23A; MICRORNA 24; MICRORNA 30E; MICRORNA 31; MICRORNA 373; MICRORNA 378; MICRORNA 424; PROCOLLAGEN PROLINE 2 OXOGLUTARATE 4 DIOXYGENASE; T LYMPHOCYTE RECEPTOR; UNCLASSIFIED DRUG; VASCULOTROPIN;

CELL FATE; CELL FUNCTION; CELL MATURATION; CELLULAR IMMUNITY; ENDOTHELIUM CELL; GENE EXPRESSION; GENE FUNCTION; GENE LOCATION; HUMAN; IMMUNE RESPONSE; IMMUNOREGULATION; IMMUNOSTIMULATION; INNATE IMMUNITY; LYMPHOCYTE PROLIFERATION; NONHUMAN; PROTEIN FUNCTION; PROTEIN TARGETING; REVIEW; RNA ANALYSIS; SIGNAL TRANSDUCTION; TUMOR ESCAPE; TUMOR GROWTH; TUMOR VASCULARIZATION;

ANGIOGENIC PROTEINS; ANIMALS; CAPILLARY PERMEABILITY; ENDOTHELIAL CELLS; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MICRORNAS; NEOPLASMS; NEOVASCULARIZATION, PATHOLOGIC; TUMOR ESCAPE; TUMOR MICROENVIRONMENT;

EID: 84879842315     PISSN: 0004069X     EISSN: 16614917     Source Type: Journal    
DOI: 10.1007/s00005-013-0231-4     Document Type: Review

References (213)

1. Androulidaki A, Iliopoulos D, Arranz A et al (2009) The kinase Akt1 controls macrophage response to lipopolysaccharide by regulating microRNAs. Immunity 31:220-231
2. Asirvatham AJ, Magner WJ, Tomasi TB (2009) miRNA regulation of cytokine genes. Cytokine 45:58-69
3. Baltimore D, Boldin MP, O'Connell RM et al (2008) MicroRNAs: new regulators of immune cell development and function. Nat Immunol 9:839-845 (Pubitemid 352038302)
4. Banerjee A, Schambach F, DeJong CS et al (2010) Micro-RNA-155 inhibits IFN-gamma signaling in CD4+ T cells. Eur J Immunol 40:225-231
5. Bazzoni F, Rossato M, Fabbri M et al (2009) Induction and regulatory function of miR-9 in human monocytes and neutrophils exposed to proinflammatory signals. Proc Natl Acad Sci USA 106:5282-5287
6. Benakanakere MR, Li Q, Eskan MA et al (2009) Modulation of TLR2 protein expression by miR-105 in human oral keratinocytes. J Biol Chem 284:23107-23115
7. Bezman NA, Cedars E, Steiner DF et al (2010) Distinct requirements of microRNAs in NK cell activation, survival, and function. J Immunol 185:3835-3846
8. Bezman NA, Chakraborty T, Bender T et al (2011) miR-150 regulates the development of NK and iNKT cells. J Exp Med 208:2717-2731
9. Bielawska-Pohl A, Blesson S, Benlalam H et al (2010) The anti-angiogenic activity of IL-12 is increased in iNOS-/- mice and involves NK cells. J Mol Med 88:775-784
10. Boldin MP, Taganov KD, Rao DS et al (2011) miR-146a is a significant brake on autoimmunity, myeloproliferation, and cancer in mice. J Exp Med 208:1189-1201
11. Bonauer A, Carmona G, Iwasaki M et al (2009) MicroRNA-92a controls angiogenesis and functional recovery of ischemic tissues in mice. Science 324:1710-1713
12. Bruning U, Cerone L, Neufeld Z et al (2011) MicroRNA-155 promotes resolution of hypoxia-inducible factor 1alpha activity during prolonged hypoxia. Mol Cell Biol 31:4087-4096
13. Bussolati B, Moggio A, Collino F et al (2012) Hypoxia modulates the undifferentiated phenotype of human renal inner medullary CD133+ progenitors through Oct4/miR-145 balance. Am J Physiol Renal Physiol 302:F116-F128
14. Calame K (2007) MicroRNA-155 function in B cells. Immunity 27:825-827 (Pubitemid 350251220)
15. Cao P, Deng Z, Wan M et al (2010) MicroRNA-101 negatively regulates Ezh2 and its expression is modulated by androgen receptor and HIF-1alpha/HIF-1beta. Mol Cancer 9:108
16. Caporali A, Emanueli C (2011) MicroRNA regulation in angiogenesis. Vascul Pharmacol 55:79-86
17. Carballo E, Lai WS, Blackshear PJ (1998) Feedback inhibition of macrophage tumor necrosis factor-alpha production by tristetraprolin. Science 281:1001-1005 (Pubitemid 28399252)
18. Cardoso AL, Guedes JR, Pereira de Almeida L et al (2012) miR-155 modulates microglia-mediated immune response by down-regulating SOCS-1 and promoting cytokine and nitric oxide production. Immunology 135:73-88
19. Carmeliet P, Jain RK (2011a) Molecular mechanisms and clinical applications of angiogenesis. Nature 473:298-307
20. Carmeliet P, Jain RK (2011b) Principles and mechanisms of vessel normalization for cancer and other angiogenic diseases. Nat Rev Drug Discov 10:417-427
21. Carreau A, Kieda C, Grillon C (2011) Nitric oxide modulates the expression of endothelial cell adhesion molecules involved in angiogenesis and leukocyte recruitment. Exp Cell Res 317:29-41
22. Cascio S, D'Andrea A, Ferla R et al (2010) miR-20b modulates VEGF expression by targeting HIF-1 alpha and STAT3 in MCF-7 breast cancer cells. J Cell Physiol 224:242-249
23. Cha ST, Chen PS, Johansson G et al (2010) MicroRNA-519c suppresses hypoxia-inducible factor-1alpha expression and tumor angiogenesis. Cancer Res 70:2675-2685
24. Chamorro-Jorganes A, Araldi E, Penalva LO et al (2011) MicroRNA-16 and microRNA-424 regulate cell-autonomous angiogenic functions in endothelial cells via targeting vascular endothelial growth factor receptor-2 and fibroblast growth factor receptor-1. Arterioscler Thromb Vasc Biol 31:2595-2606
25. Chan SY, Loscalzo J (2010) MicroRNA-210: a unique and pleiotropic hypoxamir. Cell Cycle 9:1072-1083
26. Chan YC, Khanna S, Roy S et al (2011) miR-200b targets Ets-1 and is down-regulated by hypoxia to induce angiogenic response of endothelial cells. J Biol Chem 286:2047-2056
27. Chen Y, Gorski DH (2008) Regulation of angiogenesis through a microRNA (miR-130a) that down-regulates antiangiogenic homeobox genes GAX and HOXA5. Blood 111:1217-1226 (Pubitemid 351213403)
28. Chen CZ, Li L, Lodish HF et al (2004) MicroRNAs modulate hematopoietic lineage differentiation. Science 303:83-86 (Pubitemid 38055775)
29. Cifuentes D, Xue H, Taylor DW et al (2010) A novel miRNA processing pathway independent of Dicer requires Argonaute2 catalytic activity. Science 328:1694-1698
30. Cobb BS, Hertweck A, Smith J et al (2006) A role for Dicer in immune regulation. J Exp Med 203:2519-2527 (Pubitemid 44664621)
31. Cobleigh MA, Langmuir VK, Sledge GW et al (2003) A phase I/II dose-escalation trial of bevacizumab in previously treated metastatic breast cancer. Semin Oncol 30:117-124 (Pubitemid 37433402)
32. Coffelt SB, Tal AO, Scholz A et al (2010) Angiopoietin-2 regulates gene expression in TIE2-expressing monocytes and augments their inherent proangiogenic functions. Cancer Res 70:5270-5280
33. Costinean S, Zanesi N, Pekarsky Y et al (2006) Pre-B cell proliferation and lymphoblastic leukemia/high-grade lymphoma in E(mu)-miR155 transgenic mice. Proc Natl Acad Sci USA 103:7024-7029
34. Cramer T, Johnson RS (2003) A novel role for the hypoxia inducible transcription factor HIF-1alpha: critical regulation of inflammatory cell function. Cell Cycle 2:192-193
35. Cramer T, Yamanishi Y, Clausen BE et al (2003) HIF-1alpha is essential for myeloid cell-mediated inflammation. Cell 112:645-657 (Pubitemid 36331777)
36. Crawford M, Brawner E, Batte K et al (2008) MicroRNA-126 inhibits invasion in non-small cell lung carcinoma cell lines. Biochem Biophys Res Commun 373:607-612
37. Crosby ME, Devlin CM, Glazer PM et al (2009a) Emerging roles of microRNAs in the molecular responses to hypoxia. Curr Pharm Des 15:3861-3866
38. Crosby ME, Kulshreshtha R, Ivan M et al (2009b) MicroRNA regulation of DNA repair gene expression in hypoxic stress. Cancer Res 69:1221-1229
39. Curtale G, Citarella F, Carissimi C et al (2010) An emerging player in the adaptive immune response: microRNA-146a is a modulator of IL-2 expression and activation-induced cell death in T lymphocytes. Blood 115:265-273
40. Davidson-Moncada J, Papavasiliou FN, Tam W (2010) MicroRNAs of the immune system: roles in inflammation and cancer. Ann N Y Acad Sci 1183:183-194
41. Dejean E, Renalier MH, Foisseau M et al (2011) Hypoxia-microRNA-16 downregulation induces VEGF expression in anaplastic lymphoma kinase (ALK)-positive anaplastic large-cell lymphomas. Leukemia 25:1882-1890
42. Desgrosellier JS, Cheresh DA (2010) Integrins in cancer: biological implications and therapeutic opportunities. Nat Rev Cancer 10:9-22
43. Dews M, Homayouni A, Yu D et al (2006) Augmentation of tumor angiogenesis by a Myc-activated microRNA cluster. Nat Genet 38:1060-1065 (Pubitemid 44325933)
44. Doebele C, Bonauer A, Fischer A et al (2010) Members of the microRNA-17-92 cluster exhibit a cell-intrinsic antiangiogenic function in endothelial cells. Blood 115:4944-4950
45. Du R, Sun W, Xia L et al (2012) Hypoxia-induced down-regulation of microRNA-34a promotes EMT by targeting the Notch signaling pathway in tubular epithelial cells. PLoS ONE 7:e30771
46. El Gazzar M, McCall CE (2010) MicroRNAs distinguish translational from transcriptional silencing during endotoxin tolerance. J Biol Chem 285:20940-20951
47. Falcon BL, Hashizume H, Koumoutsakos P et al (2009) Contrasting actions of selective inhibitors of angiopoietin-1 and angiopoietin-2 on the normalization of tumor blood vessels. Am J Pathol 175:2159-2170
48. Fang J, Song XW, Tian J et al (2012) Overexpression of microRNA-378 attenuates ischemia-induced apoptosis by inhibiting caspase-3 expression in cardiac myocytes. Apoptosis 17:410-423
49. Fasanaro P, D'Alessandra Y, Di Stefano V et al (2008) MicroRNA-210 modulates endothelial cell response to hypoxia and inhibits the receptor tyrosine kinase ligand Ephrin-A3. J Biol Chem 283:15878-15883
50. Fazi F, Rosa A, Fatica A et al (2005) A minicircuitry comprised of microRNA-223 and transcription factors NFI-A and C/EBPalpha regulates human granulopoiesis. Cell 123:819-831 (Pubitemid 41721029)
51. Fischer C, Jonckx B, Mazzone M et al (2007) Anti-PlGF inhibits growth of VEGF(R)-inhibitor-resistant tumors without affecting healthy vessels. Cell 131:463-475 (Pubitemid 350007692)
52. Fish JE, Santoro MM, Morton SU et al (2008) miR-126 regulates angiogenic signaling and vascular integrity. Dev Cell 15:272-284
53. Forrest AR, Kanamori-Katayama M, Tomaru Y et al (2010) Induction of microRNAs, mir-155, mir-222, mir-424 and mir-503, promotes monocytic differentiation through combinatorial regulation. Leukemia 24:460-466
54. Fukumura D, Duda DG, Munn LL et al (2010) Tumor microvasculature and microenvironment: novel insights through intravital imaging in pre-clinical models. Microcirculation 17:206-225
55. Gabrilovich DI, Chen HL, Girgis KR et al (1996) Production of vascular endothelial growth factor by human tumors inhibits the functional maturation of dendritic cells. Nat Med 2:1096-1103 (Pubitemid 26338628)
56. Ganss R, Arnold B, Hammerling GJ (2004) Mini-review: overcoming tumor-intrinsic resistance to immune effector function. Eur J Immunol 34:2635-2641 (Pubitemid 39430139)
57. Ghosh G, Subramanian IV, Adhikari N et al (2010) Hypoxia-induced microRNA-424 expression in human endothelial cells regulates HIF-alpha isoforms and promotes angiogenesis. J Clin Invest 120:4141-4154
58. Giannakakis A, Sandaltzopoulos R, Greshock J et al (2008) miR-210 links hypoxia with cell cycle regulation and is deleted in human epithelial ovarian cancer. Cancer Biol Ther 7:255-264 (Pubitemid 351590433)
59. Giantonio BJ, Catalano PJ, Meropol NJ et al (2007) Bevacizumab in combination with oxaliplatin, fluorouracil, and leucovorin (FOLFOX4) for previously treated metastatic colorectal cancer: results from the Eastern Cooperative Oncology Group Study E3200. J Clin Oncol 25:1539-1544 (Pubitemid 46733080)
60. Goel S, Duda DG, Xu L et al (2011) Normalization of the vasculature for treatment of cancer and other diseases. Physiol Rev 91:1071-1121
61. Goel S, Wong AH, Jain RK (2012) Vascular normalization as a therapeutic strategy for malignant and nonmalignant disease. Cold Spring Harb Perspect Med 2:a006486
62. Gonsalves CS, Kalra VK (2010) Hypoxia-mediated expression of 5-lipoxygenase-activating protein involves HIF-1alpha and NF-kappaB and microRNAs 135a and 199a-5p. J Immunol 184:3878-3888
63. Gordan JD, Simon MC (2007) Hypoxia-inducible factors: central regulators of the tumor phenotype. Curr Opin Genet Dev 17:71-77 (Pubitemid 46109295)
64. Griffioen AW, Damen CA, Blijham GH et al (1996) Tumor angiogenesis is accompanied by a decreased inflammatory response of tumor-associated endothelium. Blood 88:667-673 (Pubitemid 26240398)
65. Gruber M, Simon MC (2006) Hypoxia-inducible factors, hypoxia, and tumor angiogenesis. Curr Opin Hematol 13:169-174
66. Guo C, Sah JF, Beard L et al (2008) The noncoding RNA, miR-126, suppresses the growth of neoplastic cells by targeting phosphatidylinositol 3-kinase signaling and is frequently lost in colon cancers. Genes Chromosomes Cancer 47:939-946
67. Hamzah J, Jugold M, Kiessling F et al (2008) Vascular normalization in Rgs5-deficient tumours promotes immune destruction. Nature 453:410-414 (Pubitemid 351693122)
68. Haque I, Banerjee S, Mehta S et al (2011) Cysteine-rich 61-connective tissue growth factor-nephroblastoma-overexpressed 5 (CCN5)/Wnt-1-induced signaling protein-2 (WISP-2) regulates microRNA-10b via hypoxia-inducible factor-1alpha-TWIST signaling networks in human breast cancer cells. J Biol Chem 286:43475-43485
69. Harris TA, Yamakuchi M, Ferlito M et al (2008) MicroRNA-126 regulates endothelial expression of vascular cell adhesion molecule 1. Proc Natl Acad Sci USA 105:1516-1521 (Pubitemid 351346546)
70. Hartmann D, Thum T (2011) MicroRNAs and vascular (dys)function. Vascul Pharmacol 55:92-105
71. He L, Hannon GJ (2004) MicroRNAs: small RNA's with a big role in gene regulation. Nat Rev Genet 5:522-531 (Pubitemid 38868508)
72. He L, Thomson JM, Hemann MT et al (2005) A microRNA polycistron as a potential human oncogene. Nature 9:828-833 (Pubitemid 40839734)
73. Heinemann A, Zhao F, Pechlivanis S et al (2012) Tumor suppressive microRNAs miR-34a/c control cancer cell expression of ULBP2, a stress-induced ligand of the natural killer cell receptor NKG2D. Cancer Res 72:460-471
74. Hergenreider E, Heydt S, Treguer K et al (2012) Atheroprotective communication between endothelial cells and smooth muscle cells through miRNAs. Nat Cell Biol 14:249-256
75. Hockel M, Vaupel P (2001) Tumor hypoxia: definitions and current clinical, biologic, and molecular aspects. J Natl Cancer Inst 93:266-276 (Pubitemid 32219813)
76. Hockel M, Schlenger K, Hockel S et al (1999) Hypoxic cervical cancers with low apoptotic index are highly aggressive. Cancer Res 59:4525-4528 (Pubitemid 29428951)
77. Hou J, Wang P, Lin L et al (2009) MicroRNA-146a feedback inhibits RIG-I-dependent Type I IFN production in macrophages by targeting TRAF6, IRAK1, and IRAK2. J Immunol 183:2150-2158
78. Hua Z, Lv Q, Ye W et al (2006) MiRNA-directed regulation of VEGF and other angiogenic factors under hypoxia. PLoS ONE 1:e116
79. Huang X, Wong MK, Yi H et al (2002) Combined therapy of local and metastatic 4T1 breast tumor in mice using SU6668, an inhibitor of angiogenic receptor tyrosine kinases, and the immunostimulator B7.2-IgG fusion protein. Cancer Res 62:5727-5735 (Pubitemid 35204728)
80. Huang H, Bhat A, Woodnutt G et al (2010) Targeting the ANGPT-TIE2 pathway in malignancy. Nat Rev Cancer 10:575-585
81. Huang Y, Lei Y, Zhang H et al (2011a) MicroRNA regulation of STAT4 protein expression: rapid and sensitive modulation of IL-12 signaling in human natural killer cells. Blood 118:6793-6802
82. Huang Y, Snuderl M, Jain RK (2011b) Polarization of tumor-associated macrophages: a novel strategy for vascular normalization and antitumor immunity. Cancer Cell 19:1-2
83. Ivan M, Harris AL, Martelli F et al (2008) Hypoxia response and microRNAs: no longer two separate worlds. J Cell Mol Med 12:1426-1431
84. Jain RK (2001) Normalizing tumor vasculature with anti-angiogenic therapy: a new paradigm for combination therapy. Nat Med 7:987-989 (Pubitemid 32937367)
85. Jain RK (2003) Molecular regulation of vessel maturation. Nat Med 9:685-693 (Pubitemid 36749217)
86. Jain RK (2005) Normalization of tumor vasculature: an emerging concept in antiangiogenic therapy. Science 307:58-62 (Pubitemid 40093472)
87. Jain RK (2009) A new target for tumor therapy. N Engl J Med 360:2669-2671
88. Jain RK, Duda DG, Clark JW et al (2006) Lessons from phase III clinical trials on anti-VEGF therapy for cancer. Nat Clin Pract Oncol 3:24-40 (Pubitemid 43108832)
89. Jeyaseelan K, Lim KY, Armugam A (2008) MicroRNA expression in the blood and brain of rats subjected to transient focal ischemia by middle cerebral artery occlusion. Stroke 39:959-966 (Pubitemid 351619577)
90. Johnnidis JB, Harris MH, Wheeler RT et al (2008) Regulation of progenitor cell proliferation and granulocyte function by microRNA-223. Nature 451:1125-1129 (Pubitemid 351317447)
91. Jordan BF, Sonveaux P (2012) Targeting tumor perfusion and oxygenation to improve the outcome of anticancer therapy. Frontiers Pharmacol 3:94
92. Kahai S, Lee SC, Lee DY et al (2009) MicroRNA miR-378 regulates nephronectin expression modulating osteoblast differentiation by targeting GalNT-7. PLoS ONE 4:e7535
93. Kang SG, Lee WH, Lee YH et al (2012) Hypoxia-inducible factor-1alpha inhibition by a pyrrolopyrazine metabolite of oltipraz as a consequence of microRNAs 199a-5p and 20a induction. Carcinogenesis 33:661-669
94. Karaa ZS, Iacovoni JS, Bastide A et al (2009) The VEGF IRESes are differentially susceptible to translation inhibition by miR-16. RNA 15:249-254
95. Keklikoglou I, Koerner C, Schmidt C et al (2012) MicroRNA-520/373 family functions as a tumor suppressor in estrogen receptor negative breast cancer by targeting NF-kappaB and TGF-beta signaling pathways. Oncogene 31:4150-4163
96. Kieda C, Greferath R, Crola da Silva C et al (2006) Suppression of hypoxia-induced HIF-1alpha and of angiogenesis in endothelial cells by myo-inositol trispyrophosphate-treated erythrocytes. Proc Natl Acad Sci USA 103:15576-15581 (Pubitemid 44625634)
97. Kozomara A, Griffiths-Jones S (2011) miRBase: integrating microRNA annotation and deep-sequencing data. Nucleic Acids Res 39:D152-D157
98. Kuehbacher A, Urbich C, Zeiher AM et al (2007) Role of Dicer and Drosha for endothelial microRNA expression and angiogenesis. Circ Res 101:59-68 (Pubitemid 47094624)
99. Kuhnert F, Mancuso MR, Hampton J et al (2008) Attribution of vascular phenotypes of the murine Egfl7 locus to the microRNA miR-126. Development 135:3989-3993
100. Kulshreshtha R, Ferracin M, Wojcik SE et al (2007) A microRNA signature of hypoxia. Mol Cell Biol 27:1859-1867
101. Kulshreshtha R, Davuluri RV, Calin GA et al (2008) A microRNA component of the hypoxic response. Cell Death Differ 15:667-671 (Pubitemid 351405070)
102. Lai WS, Carballo E, Strum JR et al (1999) Evidence that tristetraprolin binds to AU-rich elements and promotes the deadenylation and destabilization of tumor necrosis factor alpha mRNA. Mol Cell Biol 19:4311-4323 (Pubitemid 29242006)
103. Landgraf P, Rusu M, Sheridan R et al (2007) A mammalian microRNA expression atlas based on small RNA library sequencing. Cell 129:1401-1414 (Pubitemid 46970709)
104. Larsson E, Fredlund Fuchs P, Heldin J et al (2009) Discovery of microvascular miRNAs using public gene expression data: miR-145 is expressed in pericytes and is a regulator of Fli1. Genome Med 1:108
105. le Sage C, Nagel R, Egan DA et al (2007) Regulation of the p27(Kip1) tumor suppressor by miR-221 and miR-222 promotes cancer cell proliferation. EMBO J 26:3699-3708 (Pubitemid 47236875)
106. Lee DY, Deng Z, Wang CH et al (2007) MicroRNA-378 promotes cell survival, tumor growth, and angiogenesis by targeting SuFu and Fus-1 expression. Proc Natl Acad Sci USA 104:20350-20355
107. Lei Z, Li B, Yang Z et al (2009) Regulation of HIF-1alpha and VEGF by miR-20b tunes tumor cells to adapt to the alteration of oxygen concentration. PLoS ONE 4:e7629
108. Leite de Oliveira R, Deschoemaeker S, Henze AT et al (2012) Gene-targeting of phd2 improves tumor response to chemotherapy and prevents side-toxicity. Cancer Cell 22:263-277
109. Li B, Lalani AS, Harding TC et al (2006) Vascular endothelial growth factor blockade reduces intratumoral regulatory T cells and enhances the efficacy of a GM-CSF-secreting cancer immunotherapy. Clin Cancer Res 12:6808-6816 (Pubitemid 44876851)
110. Li QJ, Chau J, Ebert PJ et al (2007) miR-181a is an intrinsic modulator of T cell sensitivity and selection. Cell 129:147-161 (Pubitemid 46507589)
111. Li Y, Song YH, Li F et al (2009) MicroRNA-221 regulates high glucose-induced endothelial dysfunction. Biochem Biophys Res Commun 381:81-83
112. Li T, Morgan MJ, Choksi S et al (2010) MicroRNAs modulate the noncanonical transcription factor NF-kappaB pathway by regulating expression of the kinase IKKalpha during macrophage differentiation. Nat Immunol 11:799-805
113. Lin YC, Kuo MW, Yu J et al (2008) c-Myb is an evolutionary conserved miR-150 target and miR-150/c-Myb interaction is important for embryonic development. Mol Biol Evol 25:2189-2198
114. Liston A, Lu LF, O'Carroll D et al (2008) Dicer-dependent microRNA pathway safeguards regulatory T cell function. J Exp Med 205:1993-2004
115. Liu P, Wilson MJ (2012) miR-520c and miR-373 upregulate MMP9 expression by targeting mTOR and SIRT1, and activate the Ras/Raf/MEK/Erk signaling pathway and NF-kappaB factor in human fibrosarcoma cells. J Cell Physiol 227:867-876
116. Liu CJ, Tsai MM, Hung PS et al (2010) miR-31 ablates expression of the HIF regulatory factor FIH to activate the HIF pathway in head and neck carcinoma. Cancer Res 70:1635-1644
117. Liu LZ, Li C, Chen Q et al (2011) MiR-21 induced angiogenesis through AKT and ERK activation and HIF-1alpha expression. PLoS ONE 6:e19139
118. Liu X, Wang Y, Sun Q et al (2012) Identification of microRNA transcriptome involved in human natural killer cell activation. Immunol Lett 143:208-217
119. Loscalzo J (2010) The cellular response to hypoxia: tuning the system with microRNAs. J Clin Invest 120:3815-3817
120. Lu LF, Rudensky A (2009) Molecular orchestration of differentiation and function of regulatory T cells. Genes Dev 23:1270-1282
121. Lu LF, Thai TH, Calado DP et al (2009) Foxp3-dependent microRNA155 confers competitive fitness to regulatory T cells by targeting SOCS1 protein. Immunity 30:80-91
122. Lu LF, Boldin MP, Chaudhry A et al (2010) Function of miR-146a in controlling Treg cell-mediated regulation of Th1 responses. Cell 142:914-929
123. Lwin T, Lin J, Choi YS et al (2010) Follicular dendritic cell-dependent drug resistance of non-Hodgkin lymphoma involves cell adhesion-mediated Bim down-regulation through induction of microRNA-181a. Blood 116:5228-5236
124. Manning EA, Ullman JG, Leatherman JM et al (2007) A vascular endothelial growth factor receptor-2 inhibitor enhances antitumor immunity through an immune-based mechanism. Clin Cancer Res 13:3951-3959 (Pubitemid 47037603)
125. Marson A, Kretschmer K, Frampton GM et al (2007) Foxp3 occupancy and regulation of key target genes during T-cell stimulation. Nature 445:931-935
126. Martello G, Zacchigna L, Inui M et al (2007) MicroRNA control of Nodal signalling. Nature 449:183-188 (Pubitemid 47402367)
127. Matejuk A, Leng Q, Chou ST et al (2011) Vaccines targeting the neovasculature of tumors. Vasc Cell 3:7
128. Matsui J, Wakabayashi T, Asada M et al (2004) Stem cell factor/c-kit signaling promotes the survival, migration, and capillary tube formation of human umbilical vein endothelial cells. J Biol Chem 279:18600-18607 (Pubitemid 38623281)
129. Mazzieri R, Pucci F, Moi D et al (2011) Targeting the ANG2/TIE2 axis inhibits tumor growth and metastasis by impairing angiogenesis and disabling rebounds of proangiogenic myeloid cells. Cancer Cell 19:512-526
130. Mazzone M, Dettori D, Leite de Oliveira R et al (2009) Heterozygous deficiency of PHD2 restores tumor oxygenation and inhibits metastasis via endothelial normalization. Cell 136:839-851
131. Melder RJ, Koenig GC, Witwer BP et al (1996) During angiogenesis, vascular endothelial growth factor and basic fibroblast growth factor regulate natural killer cell adhesion to tumor endothelium. Nat Med 2:992-997 (Pubitemid 26306837)
132. Mendell JT (2008) miRiad roles for the miR-17-92 cluster in development and disease. Cell 133:217-222 (Pubitemid 351508308)
133. Merkerova M, Belickova M, Bruchova H (2008) Differential expression of microRNAs in hematopoietic cell lineages. Eur J Haematol 81:304-310
134. Minami Y, Satoh M, Maesawa C et al (2009) Effect of atorvastatin on microRNA 221/222 expression in endothelial progenitor cells obtained from patients with coronary artery disease. Eur J Clin Invest 39:359-367
135. Mizuno S, Bogaard HJ, Gomez-Arroyo J et al (2012) MicroRNA-199a-5p is associated with hypoxia inducible factor-1alpha expression in the lung from COPD patients. Chest 142:663-672
136. Monticelli S, Ansel KM, Xiao C et al (2005) MicroRNA profiling of the murine hematopoietic system. Genome Biol 6:R71
137. Muth M, Theophile K, Hussein K et al (2010) Hypoxia-induced down-regulation of microRNA-449a/b impairs control over targeted SERPINE1 (PAI-1) mRNA - a mechanism involved in SERPINE1 (PAI-1) overexpression. J Transl Med 8:33
138. Muzio M, Bosisio D, Polentarutti N et al (2000) Differential expression and regulation of toll-like receptors (TLR) in human leukocytes: selective expression of TLR3 in dendritic cells. J Immunol 164:5998-6004 (Pubitemid 30389848)
139. Nagy JA, Chang SH, Dvorak AM et al (2009) Why are tumour blood vessels abnormal and why is it important to know? Br J Cancer 100:865-869
140. Nakashima T, Jinnin M, Etoh T et al (2010) Down-regulation of mir-424 contributes to the abnormal angiogenesis via MEK1 and cyclin E1 in senile hemangioma: its implications to therapy. PLoS ONE 5:e14334
141. Nicoli S, Standley C, Walker P et al (2010) MicroRNA-mediated integration of haemodynamics and Vegf signalling during angiogenesis. Nature 464:1196-1200
142. Nicoli S, Knyphausen CP, Zhu LJ et al (2012) miR-221 is required for endothelial tip cell behaviors during vascular development. Dev Cell 22:418-429
143. Noman MZ, Janji B, Kaminska B et al (2011) Blocking hypoxia-induced autophagy in tumors restores cytotoxic T-cell activity and promotes regression. Cancer Res 71:5976-5986
144. O'Connell RM, Taganov KD, Boldin MP et al (2007) MicroRNA-155 is induced during the macrophage inflammatory response. Proc Natl Acad Sci USA 104:1604-1609 (Pubitemid 46214637)
145. O'Connell RM, Rao DS, Chaudhuri AA et al (2008) Sustained expression of microRNA-155 in hematopoietic stem cells causes a myeloproliferative disorder. J Exp Med 205:585-594 (Pubitemid 351439306)
146. O'Connell RM, Chaudhuri AA, Rao DS et al (2009) Inositol phosphatase SHIP1 is a primary target of miR-155. Proc Natl Acad Sci USA 106:7113-7118
147. O'Connell RM, Rao DS, Chaudhuri AA et al (2010) Physiological and pathological roles for microRNAs in the immune system. Nat Rev Immunol 10:111-122
148. Okada H, Kohanbash G, Lotze MT (2010) MicroRNAs in immune regulation-opportunities for cancer immunotherapy. Int J Biochem Cell Biol 42:1256-1261
149. Olive V, Jiang I, He L (2010) mir-17-92, a cluster of miRNAs in the midst of the cancer network. Int J Biochem Cell Biol 42:1348-1354
150. Osada T, Chong G, Tansik R et al (2008) The effect of anti-VEGF therapy on immature myeloid cell and dendritic cells in cancer patients. Cancer Immunol Immunother 57:1115-1124
151. Palazon A, Aragones J, Morales-Kastresana A et al (2012) Molecular pathways: hypoxia response in immune cells fighting or promoting cancer. Clin Cancer Res 18:1207-1213
152. Poliseno L, Tuccoli A, Mariani L et al (2006) MicroRNAs modulate the angiogenic properties of HUVECs. Blood 108:3068-3071
153. Primo L, Seano G, Roca C et al (2010) Increased expression of alpha6 integrin in endothelial cells unveils a proangiogenic role for basement membrane. Cancer Res 70:5759-5769
154. Pulkkinen K, Malm T, Turunen M et al (2008) Hypoxia induces microRNA miR-210 in vitro and in vivo ephrin-A3 and neuronal pentraxin 1 are potentially regulated by miR-210. FEBS Lett 582:2397-2401
155. Rane S, He M, Sayed D et al (2009) Downregulation of miR-199a derepresses hypoxia-inducible factor-1alpha and Sirtuin 1 and recapitulates hypoxia preconditioning in cardiac myocytes. Circ Res 104:879-886
156. Redouane R, Hussein FK, Nabil EZ et al (2009) Human natural Treg microRNA signature: Role of microRNA-31 and microRNA-21 in FOXp3 expression. Eur J Immunol 39:1-11
157. Relf M, LeJeune S, Scott PA, Fox S et al (1997) Expression of the angiogenic factors vascular endothelial cell growth factor, acidic and basic fibroblast growth factor, tumor growth factor beta-1, platelet-derived endothelial cell growth factor, placenta growth factor, and pleiotrophin in human primary breast cancer and its relation to angiogenesis. Cancer Res 57:963-969 (Pubitemid 27098025)
158. Rocha S (2007) Gene regulation under low oxygen: holding your breath for transcription. Trends Biochem Sci 32:389-397 (Pubitemid 47126857)
159. Rodriguez A, Vigorito E, Clare S et al (2007) Requirement of bic/microRNA-155 for normal immune function. Science 316:608-611 (Pubitemid 46683148)
160. Rolny C, Mazzone M, Tugues S et al (2011) HRG inhibits tumor growth and metastasis by inducing macrophage polarization and vessel normalization through downregulation of PlGF. Cancer Cell 19:31-44
161. Rosa A, Ballarino M, Sorrentino A et al (2007) The interplay between the master transcription factor PU.1 and miR-424 regulates human monocyte/macrophage differentiation. Proc Natl Acad Sci USA 104:19849-19854
162. Saito K, Kondo E, Matsushita M (2011) MicroRNA 130 family regulates the hypoxia response signal through the P-body protein DDX6. Nucleic Acids Res 39:6086-6099
163. Saltz LB, Clarke S, Diaz-Rubio E et al (2008) Bevacizumab in combination with oxaliplatin-based chemotherapy as first-line therapy in metastatic colorectal cancer: a randomized phase III study. J Clin Oncol 26:2013-2019
164. Sasaki K, Kohanbash G, Hoji A et al (2010) miR-17-92 expression in differentiated T cells - implications for cancer immunotherapy. J Transl Med 8:17
165. Sheedy FJ, Palsson-McDermott E, Hennessy EJ et al (2010) Negative regulation of TLR4 via targeting of the proinflammatory tumor suppressor PDCD4 by the microRNA miR-21. Nat Immunol 11:141-147
166. Shilo S, Roy S, Khanna S et al (2008) Evidence for the involvement of miRNA in redox regulated angiogenic response of human microvascular endothelial cells. Arterioscler Thromb Vasc Biol 28:471-477
167. Shojaei F, Wu X, Malik AK et al (2007) Tumor refractoriness to anti-VEGF treatment is mediated by CD11b+ Gr1+ myeloid cells. Nat Biotechnol 25:911-920 (Pubitemid 47236916)
168. Shrimali RK, Yu Z, Theoret MR et al (2010) Antiangiogenic agents can increase lymphocyte infiltration into tumor and enhance the effectiveness of adoptive immunotherapy of cancer. Cancer Res 70:6171-6180
169. Sihn G, Walter T, Klein JC et al (2007) Anti-angiogenic properties of myo-inositol trispyrophosphate in ovo and growth reduction of implanted glioma. FEBS Lett 581:962-966
170. Skuli N, Monferran S, Delmas C et al (2009) Alphavbeta3/alphavbeta5 integrins-FAK-RhoB: a novel pathway for hypoxia regulation in glioblastoma. Cancer Res 69:3308-3316
171. Song T, Zhang X, Wang C et al (2011) MiR-138 suppresses expression of hypoxia-inducible factor 1alpha (HIF-1alpha) in clear cell renal cell carcinoma 786-O cells. Asian Pac J Cancer Prev 12:1307-1311
172. Sonkoly E, Stahle M, Pivarcsi A (2008) MicroRNAs and immunity: novel players in the regulation of normal immune function and inflammation. Semin Cancer Biol 18:131-140
173. Starczynowski DT, Kuchenbauer F, Argiropoulos B et al (2010) Identification of miR-145 and miR-146a as mediators of the 5q- syndrome phenotype. Nat Med 16:49-58
174. Stockmann C, Doedens A, Weidemann A et al (2008) Deletion of vascular endothelial growth factor in myeloid cells accelerates tumorigenesis. Nature 456:814-818
175. Suarez Y, Fernandez-Hernando C, Pober JS et al (2007) Dicer dependent microRNAs regulate gene expression and functions in human endothelial cells. Circ Res 100:1164-1173 (Pubitemid 46684129)
176. Suarez Y, Fernandez-Hernando C, Yu J et al (2008) Dicer-dependent endothelial microRNAs are necessary for postnatal angiogenesis. Proc Natl Acad Sci USA 105:14082-14087
177. Sullivan RP, Leong JW, Schneider SE et al (2012) MicroRNA-deficient NK cells exhibit decreased survival but enhanced function. J Immunol 188:3019-3030
178. Taganov KD, Boldin MP, Chang KJ et al (2006) NF-kappaB-dependent induction of microRNA miR-146, an inhibitor targeted to signaling proteins of innate immune responses. Proc Natl Acad Sci USA 103:12481-12486 (Pubitemid 44267285)
179. Taguchi A, Yanagisawa K, Tanaka M et al (2008) Identification of hypoxia-inducible factor-1 alpha as a novel target for miR-17-92 microRNA cluster. Cancer Res 68:5540-5545
180. Tanaka T, Arai M, Wu S et al (2011) Epigenetic silencing of microRNA-373 plays an important role in regulating cell proliferation in colon cancer. Oncol Rep 26:1329-1335
181. Tang Y, Luo X, Cui H et al (2009) MicroRNA-146A contributes to abnormal activation of the type I interferon pathway in human lupus by targeting the key signaling proteins. Arthr Rheum 60:1065-1075
182. Tavazoie SF, Alarcon C, Oskarsson T et al (2008) Endogenous human microRNAs that suppress breast cancer metastasis. Nature 451:147-152
183. Tebbutt NC, Wilson K, Gebski VJ et al (2010) Capecitabine, bevacizumab, and mitomycin in first-line treatment of metastatic colorectal cancer: results of the Australasian Gastrointestinal Trials Group Randomized Phase III MAX Study. J Clin Oncol 28:3191-3198
184. Teicher BA (1996) A systems approach to cancer therapy. (Antioncogenics + standard cytotoxics->mechanism(s) of interaction). Cancer Metastasis Rev 15:247-272 (Pubitemid 26236124)
185. Thai TH, Calado DP, Casola S et al (2007) Regulation of the germinal center response by microRNA-155. Science 316:604-608 (Pubitemid 46683147)
186. Thiel M, Caldwell CC, Kreth S et al (2007) Targeted deletion of HIF-1alpha gene in T cells prevents their inhibition in hypoxic inflamed tissues and improves septic mice survival. PLoS ONE 2:e853 (Pubitemid 351420356)
187. Thomas MD, Kremer CS, Ravichandran KS et al (2005) c-Myb is critical for B cell development and maintenance of follicular B cells. Immunity 23:275-286 (Pubitemid 41317795)
188. Thomas M, Lieberman J, Lal A (2010) Desperately seeking microRNA targets. Nat Struct Mol Biol 17:1169-1174
189. Tili E, Michaille JJ, Cimino A et al (2007) Modulation of miR-155 and miR-125b levels following lipopolysaccharide/TNF-alpha stimulation and their possible roles in regulating the response to endotoxin shock. J Immunol 179:5082-5089
190. Tong RT, Boucher Y, Kozin SV et al (2004) Vascular normalization by vascular endothelial growth factor receptor 2 blockade induces a pressure gradient across the vasculature and improves drug penetration in tumors. Cancer Res 64:3731-3736 (Pubitemid 38697278)
191. Tsitsiou E, Lindsay MA (2009) microRNAs and the immune response. Curr Opin Pharmacol 9:514-520
192. Tsuchiya S, Fujiwara T, Sato F et al (2011) MicroRNA-210 regulates cancer cell proliferation through targeting fibroblast growth factor receptor-like 1 (FGFRL1). J Biol Chem 286:420-428
193. Ueda R, Kohanbash G, Sasaki K et al (2009) Dicer-regulated microRNAs 222 and 339 promote resistance of cancer cells to cytotoxic T-lymphocytes by down-regulation of ICAM-1. Proc Natl Acad Sci USA 106:10746-10751
194. Urbich C, Kaluza D, Fromel T et al (2012) MicroRNA-27a/b controls endothelial cell repulsion and angiogenesis by targeting semaphorin 6A. Blood 119:1607-1616
195. Van de Veire S, Stalmans I, Heindryckx F et al (2010) Further pharmacological and genetic evidence for the efficacy of PlGF inhibition in cancer and eye disease. Cell 141:178-190
196. van Solingen C, Seghers L, Bijkerk R et al (2009) Antagomir-mediated silencing of endothelial cell specific microRNA-126 impairs ischemia-induced angiogenesis. J Cell Mol Med 13:1577-1585
197. Wang S, Olson EN (2009) AngiomiRs-key regulators of angiogenesis. Curr Opin Genet Dev 19:205-211
198. Wang S, Aurora AB, Johnson BA et al (2008) The endothelial-specific microRNA miR-126 governs vascular integrity and angiogenesis. Dev Cell 15:261-271
199. Wang P, Gu Y, Zhang Q et al (2012) Identification of resting and type I IFN-activated human NK cell miRNomes reveals microRNA-378 and microRNA-30e as negative regulators of NK cell cytotoxicity. J Immunol 189:211-221
200. Wildiers H, Guetens G, De Boeck G et al (2003) Effect of antivascular endothelial growth factor treatment on the intratumoral uptake of CPT-11. Br J Cancer 88:1979-1986 (Pubitemid 36829677)
201. Winter J, Jung S, Keller S et al (2009) Many roads to maturity: microRNA biogenesis pathways and their regulation. Nat Cell Biol 11:228-234
202. Wurdinger T, Tannous BA, Saydam O et al (2008) miR-296 regulates growth factor receptor overexpression in angiogenic endothelial cells. Cancer Cell 14:382-393
203. Xiao C, Calado DP, Galler G et al (2007) MiR-150 controls B cell differentiation by targeting the transcription factor c-Myb. Cell 131:146-159 (Pubitemid 47498525)
204. Xiao C, Srinivasan L, Calado DP et al (2008) Lymphoproliferative disease and autoimmunity in mice with increased miR-17-92 expression in lymphocytes. Nat Immunol 9:405-414 (Pubitemid 351405110)
205. Xu Q, Liu LZ, Qian X et al (2012) MiR-145 directly targets p70S6K1 in cancer cells to inhibit tumor growth and angiogenesis. Nucleic Acids Res 40:761-774
206. Yamakuchi M, Lotterman CD, Bao C et al (2010) P53-induced microRNA-107 inhibits HIF-1 and tumor angiogenesis. Proc Natl Acad Sci USA 107:6334-6339
207. Yamakuchi M, Yagi S, Ito T et al (2011) MicroRNA-22 regulates hypoxia signaling in colon cancer cells. PLoS ONE 6:e20291
208. Yang WJ, Yang DD, Na S et al (2005) Dicer is required for embryonic angiogenesis during mouse development. J Biol Chem 280:9330-9335 (Pubitemid 40409626)
209. Zhao JL, Rao DS, Boldin MP et al (2011) NF-kappaB dysregulation in microRNA-146a-deficient mice drives the development of myeloid malignancies. Proc Natl Acad Sci USA 108:9184-9189
210. Zheng Y, Josefowicz SZ, Kas A et al (2007) Genome-wide analysis of Foxp3 target genes in developing and mature regulatory T cells. Nature 445:936-940
211. Zhou X, Jeker LT, Fife BT et al (2008) Selective miRNA disruption in T reg cells leads to uncontrolled autoimmunity. J Exp Med 205:1983-1991
212. Zhou Q, Gallagher R, Ufret-Vincenty R et al (2011) Regulation of angiogenesis and choroidal neovascularization by members of microRNA-23~27~24 clusters. Proc Natl Acad Sci USA 108:8287-8292
213. Zhu QY, Liu Q, Chen JX et al (2010) MicroRNA-101 targets MAPK phosphatase-1 to regulate the activation of MAPKs in macrophages. J Immunol 185:7435-7442